Multiples-led consortium to acquire a 9.3% stake in BDR Pharmaceuticals for $91m.

Multiples, a private equity firm, Times Group, a media conglomerate, QRG Invest, Nishant Agarwal and Mallika Srinivasan agreed to acquire a 9.3% stake in BDR Pharmaceuticals, a pharmaceutical company, for $91m. "It is our pleasure to partner Multiples, as our first PE investor. Multiples is an active investor in the pharmaceuticals sector and have a strong track record of partnering with visionary entrepreneurs and management teams in helping them in their transformation journeys,” Dharmesh Shah, BDR Pharmaceuticals Chairman and Managing Director.